Skip to main content

22.04.2024 | Original Article

Imaging findings of children with PTEN-related hamartoma tumor syndrome: a 20-year multicentric pediatric cohort

verfasst von: Claudia Martinez-Rios, Laura S. De Leon Benedetti, Luis Octavio Tierradentro-Garcia, Ozge Aksel Kilicarslan, Pablo Caro-Dominguez, Hansel J. Otero

Erschienen in: Pediatric Radiology

Einloggen, um Zugang zu erhalten

Abstract

Background

PTEN-related hamartoma tumor syndrome results from a mutation in the PTEN gene located at 10q23.31. This syndrome represents a spectrum of different phenotypes of variable expressions, now recognized as part of the same condition. Patients with this mutation have an increased risk of developing a wide range of findings, including malignancies. Although widely described in adults, there are no large series describing the imaging findings in patients before adulthood. Knowledge of the findings seen in children and adolescents with PTEN-related hamartoma tumor syndrome can help guide further management and improve surveillance recommendations.

Objective

To describe the spectrum of imaging abnormalities in pediatric patients with PTEN-related hamartoma tumor syndrome.

Materials and methods

We performed a retrospective, cross-sectional, multicenter study conducted between January 2000 and October 2021 in three tertiary pediatric institutions evaluating the imaging findings in children and adolescents (≤ 18 years) with confirmed diagnoses of a PTEN mutation. For each patient, the imaging findings, histopathology reports, and at least a 2-year follow-up of clinical outcomes for non-operative cases were documented.

Results

The cohort included 78 children (37 girls), with a mean age at diagnosis of 7.5 years (range 0 days to 18 years). Benign brain findings included enlarged Virchow-Robin perivascular spaces, white matter changes, developmental venous anomalies, and cerebellar hamartomas. Benign thyroid findings were common, but 5/45 (11.1%) with thyroid abnormalities had a malignant nodule. Soft tissue adipocytic tumors, GI/GU polyps, other soft tissue abnormalities, along with vascular anomalies in various anatomic locations were common.

Conclusion

Brain abnormalities, benign non-vascular soft tissue abnormalities, and vascular anomalies are commonly seen in children and adolescents with PTEN-related hamartoma tumor syndrome. However, malignancies involving the thyroid gland are not uncommon. Familiarity with the phenotype of PTEN-related hamartoma tumor syndrome in the pediatric population can improve diagnosis and prompt appropriate clinical surveillance of abnormal findings that warrant further management.

Graphical abstract

Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Hobert JA, Eng C (2009) PTEN hamartoma tumor syndrome: an overview. Genet Med Oct 11(10):687–694CrossRef Hobert JA, Eng C (2009) PTEN hamartoma tumor syndrome: an overview. Genet Med Oct 11(10):687–694CrossRef
2.
Zurück zum Zitat Macken WL, Tischkowitz M, Lachlan KL (2019) PTEN Hamartoma tumor syndrome in childhood: a review of the clinical literature. Am J Med Genet C Semin Med Genet Dec 181(4):591–610CrossRef Macken WL, Tischkowitz M, Lachlan KL (2019) PTEN Hamartoma tumor syndrome in childhood: a review of the clinical literature. Am J Med Genet C Semin Med Genet Dec 181(4):591–610CrossRef
3.
Zurück zum Zitat Yehia L, Eng C (2020) PTEN hamartoma tumour syndrome: what happens when there is no PTEN germline mutation? Hum Mol Genet Oct 20(R2):R150–R157CrossRef Yehia L, Eng C (2020) PTEN hamartoma tumour syndrome: what happens when there is no PTEN germline mutation? Hum Mol Genet Oct 20(R2):R150–R157CrossRef
4.
Zurück zum Zitat Ciaccio C, Saletti V, D’Arrigo S, Esposito S, Alfei E, Moroni I, Tonduti D, Chiapparini L, Pantaleoni C, Milani D (2019) Clinical spectrum of PTEN mutation in pediatric patients. A bicenter experience. Eur J Med Genet Dec 62(12):103596CrossRef Ciaccio C, Saletti V, D’Arrigo S, Esposito S, Alfei E, Moroni I, Tonduti D, Chiapparini L, Pantaleoni C, Milani D (2019) Clinical spectrum of PTEN mutation in pediatric patients. A bicenter experience. Eur J Med Genet Dec 62(12):103596CrossRef
5.
Zurück zum Zitat Yehia L, Ngeow J, Eng C (2019) PTEN-opathies: from biological insights to evidence-based precision medicine. J Clin Invest Feb 1(2):452–464CrossRef Yehia L, Ngeow J, Eng C (2019) PTEN-opathies: from biological insights to evidence-based precision medicine. J Clin Invest Feb 1(2):452–464CrossRef
6.
Zurück zum Zitat Álvarez-Garcia V, Tawil Y, Wise HM, Leslie NR (2019) Mechanisms of PTEN loss in cancer: it’s all about diversity. Semin Cancer Biol Dec 59:66–79CrossRef Álvarez-Garcia V, Tawil Y, Wise HM, Leslie NR (2019) Mechanisms of PTEN loss in cancer: it’s all about diversity. Semin Cancer Biol Dec 59:66–79CrossRef
7.
Zurück zum Zitat Leslie NR, Longy M (2016) Inherited PTEN mutations and the prediction of phenotype. Semin Cell Dev Biol Apr 52:30–38CrossRef Leslie NR, Longy M (2016) Inherited PTEN mutations and the prediction of phenotype. Semin Cell Dev Biol Apr 52:30–38CrossRef
8.
Zurück zum Zitat Zou Z, Tao T, Li H, Zhu X (2020) mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges. Cell Biosci Mar 10:10:31CrossRef Zou Z, Tao T, Li H, Zhu X (2020) mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges. Cell Biosci Mar 10:10:31CrossRef
9.
Zurück zum Zitat Jonker LA, Lebbink CA, Jongmans MCJ, Nievelstein RAJ, Merks JHM, van Nieveen EJM, Links TP, Hoogerbrugge N, van Trotsenburg ASP, van Santen HM (2020) Recommendations on surveillance for differentiated thyroid carcinoma in children with PTEN hamartoma tumor syndrome. Eur Thyroid J Sep 9(5):234–242CrossRef Jonker LA, Lebbink CA, Jongmans MCJ, Nievelstein RAJ, Merks JHM, van Nieveen EJM, Links TP, Hoogerbrugge N, van Trotsenburg ASP, van Santen HM (2020) Recommendations on surveillance for differentiated thyroid carcinoma in children with PTEN hamartoma tumor syndrome. Eur Thyroid J Sep 9(5):234–242CrossRef
10.
Zurück zum Zitat Nasr Y, Bettoli M, El Demellawy D, Sekhon H, de Nanassy J (2019) Sclerosing pneumocytoma of the lungs arising in a child with PTEN mutation. Pediatr Dev Pathol Nov-Dec 22(6):579–583CrossRef Nasr Y, Bettoli M, El Demellawy D, Sekhon H, de Nanassy J (2019) Sclerosing pneumocytoma of the lungs arising in a child with PTEN mutation. Pediatr Dev Pathol Nov-Dec 22(6):579–583CrossRef
11.
Zurück zum Zitat Plamper M, Born M, Gohlke B, Schreiner F, Schulte S, Splittstößer V, Woelfle J (2020) Cerebral MRI and clinical findings in children with PTEN hamartoma tumor syndrome: can cerebral MRI scan help to establish an earlier diagnosis of PHTS in Children? Cells Jul 10(7):1668CrossRef Plamper M, Born M, Gohlke B, Schreiner F, Schulte S, Splittstößer V, Woelfle J (2020) Cerebral MRI and clinical findings in children with PTEN hamartoma tumor syndrome: can cerebral MRI scan help to establish an earlier diagnosis of PHTS in Children? Cells Jul 10(7):1668CrossRef
12.
Zurück zum Zitat Smpokou P, Fox VL, Tan WH (2015) PTEN hamartoma tumour syndrome: early tumour development in children. Arch Dis Child Jan 100(1):34–37CrossRef Smpokou P, Fox VL, Tan WH (2015) PTEN hamartoma tumour syndrome: early tumour development in children. Arch Dis Child Jan 100(1):34–37CrossRef
13.
Zurück zum Zitat Tan MH, Mester JL, Ngeow J, Rybicki LA, Orloff MS, Eng C (2012) Lifetime cancer risks in individuals with germline PTEN mutations. Clin Cancer Res Jan 15(2):400–407CrossRef Tan MH, Mester JL, Ngeow J, Rybicki LA, Orloff MS, Eng C (2012) Lifetime cancer risks in individuals with germline PTEN mutations. Clin Cancer Res Jan 15(2):400–407CrossRef
14.
Zurück zum Zitat Balci TB, Davila J, Lewis D, Boafo A, Sell E, Richer J, Nikkel SM, Armour CM, Tomiak E, Lines MA, Sawyer SL (2018) Broad spectrum of neuropsychiatric phenotypes associated with white matter disease in PTEN hamartoma tumor syndrome. Am J Med Genet B Neuropsychiatr Genet Jan 177(1):101–109CrossRef Balci TB, Davila J, Lewis D, Boafo A, Sell E, Richer J, Nikkel SM, Armour CM, Tomiak E, Lines MA, Sawyer SL (2018) Broad spectrum of neuropsychiatric phenotypes associated with white matter disease in PTEN hamartoma tumor syndrome. Am J Med Genet B Neuropsychiatr Genet Jan 177(1):101–109CrossRef
15.
Zurück zum Zitat Dhamija R, Hoxworth JM (2020) Imaging of PTEN-related abnormalities in the central nervous system. Clin Imaging Apr 60(2):180–185CrossRef Dhamija R, Hoxworth JM (2020) Imaging of PTEN-related abnormalities in the central nervous system. Clin Imaging Apr 60(2):180–185CrossRef
16.
Zurück zum Zitat Lok C, Viseux V, Avril MF, Richard MA, Gondry-Jouet C, Deramond H, Desfossez-Tribout C, Courtade S, Delaunay M, Piette F, Legars D, Dreno B, Saïag P, Longy M, Lorette G, Laroche L, Caux F, Cancerology Group of the French Society of Dermatology (2005) Brain magnetic resonance imaging in patients with Cowden syndrome. Med (Baltimore) Mar 84(2):129–136CrossRef Lok C, Viseux V, Avril MF, Richard MA, Gondry-Jouet C, Deramond H, Desfossez-Tribout C, Courtade S, Delaunay M, Piette F, Legars D, Dreno B, Saïag P, Longy M, Lorette G, Laroche L, Caux F, Cancerology Group of the French Society of Dermatology (2005) Brain magnetic resonance imaging in patients with Cowden syndrome. Med (Baltimore) Mar 84(2):129–136CrossRef
17.
Zurück zum Zitat Vanderver A, Tonduti D, Kahn I, Schmidt J, Medne L, Vento J, Chapman KA, Lanpher B, Pearl P, Gropman A, Lourenco C, Bamforth JS, Sharpe C, Pineda M, Schallner J, Bodamer O, Orcesi S, Oberstein SA, Sistermans EA, Yntema HG, Bonnemann C, Waldman AT, van der Knaap MS (2014) Characteristic brain magnetic resonance imaging pattern in patients with macrocephaly and PTEN mutations. Am J Med Genet Mar 164A(3):627–633CrossRef Vanderver A, Tonduti D, Kahn I, Schmidt J, Medne L, Vento J, Chapman KA, Lanpher B, Pearl P, Gropman A, Lourenco C, Bamforth JS, Sharpe C, Pineda M, Schallner J, Bodamer O, Orcesi S, Oberstein SA, Sistermans EA, Yntema HG, Bonnemann C, Waldman AT, van der Knaap MS (2014) Characteristic brain magnetic resonance imaging pattern in patients with macrocephaly and PTEN mutations. Am J Med Genet Mar 164A(3):627–633CrossRef
18.
Zurück zum Zitat Dragoo DD, Taher A, Wong VK, Elsaiey A, Consul N, Mahmoud HS, Mujtaba B, Stanietzky N, Elsayes KM (2021) PTEN Hamartoma Tumor Syndrome/Cowden Syndrome: Genomics, Oncogenesis, and Imaging Review for Associated Lesions and Malignancy. Cancers (Basel) Jun 22;13(13):3120 Dragoo DD, Taher A, Wong VK, Elsaiey A, Consul N, Mahmoud HS, Mujtaba B, Stanietzky N, Elsayes KM (2021) PTEN Hamartoma Tumor Syndrome/Cowden Syndrome: Genomics, Oncogenesis, and Imaging Review for Associated Lesions and Malignancy. Cancers (Basel) Jun 22;13(13):3120
19.
Zurück zum Zitat Golpanian S, Perez EA, Tashiro J, Lew JI, Sola JE, Hogan AR (2016) Pediatric papillary thyroid carcinoma: outcomes and survival predictors in 2504 surgical patients. Pediatr Surg Int Mar 32(3):201–208CrossRef Golpanian S, Perez EA, Tashiro J, Lew JI, Sola JE, Hogan AR (2016) Pediatric papillary thyroid carcinoma: outcomes and survival predictors in 2504 surgical patients. Pediatr Surg Int Mar 32(3):201–208CrossRef
20.
Zurück zum Zitat Baran JA, Tsai SD, Isaza A, Brodeur GM, MacFarland SP, Zelley K, Adams DM, Franco AT, Bauer AJ (2020) The clinical spectrum of PTEN hamartoma tumor syndrome: exploring the value of thyroid surveillance. Horm Res Paediatr 93(11–12):634–642CrossRefPubMed Baran JA, Tsai SD, Isaza A, Brodeur GM, MacFarland SP, Zelley K, Adams DM, Franco AT, Bauer AJ (2020) The clinical spectrum of PTEN hamartoma tumor syndrome: exploring the value of thyroid surveillance. Horm Res Paediatr 93(11–12):634–642CrossRefPubMed
21.
Zurück zum Zitat Tischkowitz M, Colas C, Pouwels S, Hoogerbrugge N, PHTS Guideline Development Group; European Reference Network GENTURIS (2020) Cancer Surveillance Guideline for individuals with PTEN hamartoma tumour syndrome. Eur J Hum Genet Oct 28(10):1387–1393CrossRef Tischkowitz M, Colas C, Pouwels S, Hoogerbrugge N, PHTS Guideline Development Group; European Reference Network GENTURIS (2020) Cancer Surveillance Guideline for individuals with PTEN hamartoma tumour syndrome. Eur J Hum Genet Oct 28(10):1387–1393CrossRef
22.
Zurück zum Zitat Plitt G, Brewer T, Yehia L, Jin J, Shin J, Eng C (2022) Development and progression of thyroid disease in PTEN hamartoma tumor syndrome: refined surveillance recommendations. Thyroid Sep 32(9):1094–1100CrossRef Plitt G, Brewer T, Yehia L, Jin J, Shin J, Eng C (2022) Development and progression of thyroid disease in PTEN hamartoma tumor syndrome: refined surveillance recommendations. Thyroid Sep 32(9):1094–1100CrossRef
23.
Zurück zum Zitat Guerra-Gutiérrez F, Torres Sánchez I, Gallardo-Madueño G, Mariño-Enríquez A, Nistal M (2007) Hemangioma Esclerosante pulmonar en un paciente con síndrome de Cowden [Pulmonary sclerosing hemangioma in a patient with Cowden syndrome]. Arch Bronconeumol Jul 43(7):418–420 Guerra-Gutiérrez F, Torres Sánchez I, Gallardo-Madueño G, Mariño-Enríquez A, Nistal M (2007) Hemangioma Esclerosante pulmonar en un paciente con síndrome de Cowden [Pulmonary sclerosing hemangioma in a patient with Cowden syndrome]. Arch Bronconeumol Jul 43(7):418–420
24.
Zurück zum Zitat Yalcin B, Bekci TT, Kozacioglu S, Bolukbas O (2019) Pulmonary sclerosing pneumocytoma, a rare tumor of the lung. Respir Med Case Rep Feb 13:26:285–287 Yalcin B, Bekci TT, Kozacioglu S, Bolukbas O (2019) Pulmonary sclerosing pneumocytoma, a rare tumor of the lung. Respir Med Case Rep Feb 13:26:285–287
25.
Zurück zum Zitat Martin H, Bessis D, Bourrat E, Mazereeuw-Hautier J, Morice-Picard F, Balguerie X, Chiaverini C (2020) Cutaneous lipomas and macrocephaly as early signs of PTEN hamartoma tumor syndrome. Pediatr Dermatol Sep 37(5):839–843Groupe de Recherche de la Société Française de Dermatologie Pédiatrique Martin H, Bessis D, Bourrat E, Mazereeuw-Hautier J, Morice-Picard F, Balguerie X, Chiaverini C (2020) Cutaneous lipomas and macrocephaly as early signs of PTEN hamartoma tumor syndrome. Pediatr Dermatol Sep 37(5):839–843Groupe de Recherche de la Société Française de Dermatologie Pédiatrique
26.
Zurück zum Zitat Kurek KC, Howard E, Tennant LB, Upton J, Alomari AI, Burrows PE, Chalache K, Harris DJ, Trenor CC 3rd, Eng C, Fishman SJ, Mulliken JB, Perez-Atayde AR, Kozakewich HP (2012) PTEN hamartoma of soft tissue: a distinctive lesion in PTEN syndromes. Am J Surg Pathol May 36(5):671–687CrossRef Kurek KC, Howard E, Tennant LB, Upton J, Alomari AI, Burrows PE, Chalache K, Harris DJ, Trenor CC 3rd, Eng C, Fishman SJ, Mulliken JB, Perez-Atayde AR, Kozakewich HP (2012) PTEN hamartoma of soft tissue: a distinctive lesion in PTEN syndromes. Am J Surg Pathol May 36(5):671–687CrossRef
27.
Zurück zum Zitat Gurunathan A, Ricci K, Iacobas I, Rednam SP, Wusik K, Fei L, Hammilll AM (2020) Impact of vascular anomalies on the PTEN phenotype in children and young adults. Pediatr Blood Cancer Jun 67(6):e28258CrossRef Gurunathan A, Ricci K, Iacobas I, Rednam SP, Wusik K, Fei L, Hammilll AM (2020) Impact of vascular anomalies on the PTEN phenotype in children and young adults. Pediatr Blood Cancer Jun 67(6):e28258CrossRef
28.
Zurück zum Zitat Chism CB, Crawford L, Tchakarov A, Al-Ibraheemi A, Beckmann NM (2017) PTEN hamartoma of the soft tissue: the initial manifestation of an underlying PTEN hamartoma tumor syndrome in a 4-year-old female. Skeletal Radiol Nov 46(11):1591–1595CrossRef Chism CB, Crawford L, Tchakarov A, Al-Ibraheemi A, Beckmann NM (2017) PTEN hamartoma of the soft tissue: the initial manifestation of an underlying PTEN hamartoma tumor syndrome in a 4-year-old female. Skeletal Radiol Nov 46(11):1591–1595CrossRef
30.
Zurück zum Zitat Farooq A, Walker LJ, Bowling J, Audisio RA (2010) Cowden syndrome. Cancer Treat Rev Dec 36(8):577–583CrossRef Farooq A, Walker LJ, Bowling J, Audisio RA (2010) Cowden syndrome. Cancer Treat Rev Dec 36(8):577–583CrossRef
31.
Zurück zum Zitat Nelen MR, Kremer H, Konings IB, Schoute F, van Essen AJ, Koch R, Woods CG, Fryns JP, Hamel B, Hoefsloot LH, Peeters EA, Padberg GW (1999) Novel PTEN mutations in patients with Cowden disease: absence of clear genotype-phenotype correlations. Eur J Hum Genet Apr 7(3):267–273CrossRef Nelen MR, Kremer H, Konings IB, Schoute F, van Essen AJ, Koch R, Woods CG, Fryns JP, Hamel B, Hoefsloot LH, Peeters EA, Padberg GW (1999) Novel PTEN mutations in patients with Cowden disease: absence of clear genotype-phenotype correlations. Eur J Hum Genet Apr 7(3):267–273CrossRef
33.
Zurück zum Zitat Plamper M, Gohlke B, Woelfle J (2022) PTEN hamartoma tumor syndrome in childhood and adolescence-a comprehensive review and presentation of the German pediatric guideline. Mol Cell Pediatr Feb 21;9(1):3 Plamper M, Gohlke B, Woelfle J (2022) PTEN hamartoma tumor syndrome in childhood and adolescence-a comprehensive review and presentation of the German pediatric guideline. Mol Cell Pediatr Feb 21;9(1):3
34.
Zurück zum Zitat Yehia L, Plitt G, Tushar AM, Joo J, Burke CA, Campbell SC, Heiden K, Jin J, Macaron C, Michener CM, Pederson HJ, Radhakrishnan K, Shin J, Tamburro J, Patil S, Eng C (2023) Longitudinal analysis of cancer risk in children and adults with germline PTEN variants. JAMA Netw Open Apr 36(4):e239705CrossRef Yehia L, Plitt G, Tushar AM, Joo J, Burke CA, Campbell SC, Heiden K, Jin J, Macaron C, Michener CM, Pederson HJ, Radhakrishnan K, Shin J, Tamburro J, Patil S, Eng C (2023) Longitudinal analysis of cancer risk in children and adults with germline PTEN variants. JAMA Netw Open Apr 36(4):e239705CrossRef
35.
Zurück zum Zitat Daly MB, Pilarski R, Axilbund JE, Buys SS, Crawford B, Friedman S, Garber JE, Horton C, Kaklamani V, Klein C, Kohlmann W, Kurian A, Litton J, Madlensky L, Marcom PK, Merajver SD, Offit K, Pal T, Pasche B, Reiser G, Shannon KM, Swisher E, Voian NC, Weitzel JN, Whelan A, Wiesner GL, Dwyer MA, Kumar R, National comprehensive cancer network (2014) Genetic/familial high-risk assessment: breast and ovarian, version 1.2014. J Natl Compr Canc Netw Sep 12(9):1326–1338CrossRef Daly MB, Pilarski R, Axilbund JE, Buys SS, Crawford B, Friedman S, Garber JE, Horton C, Kaklamani V, Klein C, Kohlmann W, Kurian A, Litton J, Madlensky L, Marcom PK, Merajver SD, Offit K, Pal T, Pasche B, Reiser G, Shannon KM, Swisher E, Voian NC, Weitzel JN, Whelan A, Wiesner GL, Dwyer MA, Kumar R, National comprehensive cancer network (2014) Genetic/familial high-risk assessment: breast and ovarian, version 1.2014. J Natl Compr Canc Netw Sep 12(9):1326–1338CrossRef
Metadaten
Titel
Imaging findings of children with PTEN-related hamartoma tumor syndrome: a 20-year multicentric pediatric cohort
verfasst von
Claudia Martinez-Rios
Laura S. De Leon Benedetti
Luis Octavio Tierradentro-Garcia
Ozge Aksel Kilicarslan
Pablo Caro-Dominguez
Hansel J. Otero
Publikationsdatum
22.04.2024
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Radiology
Print ISSN: 0301-0449
Elektronische ISSN: 1432-1998
DOI
https://doi.org/10.1007/s00247-024-05922-8

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärztinnen und Psychotherapeuten.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.